AN2 Therapeutics Inc (ANTX)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | 2025-01-03 | PS Planned sale |
Chief Financial Officer Officer |
2,957
-8.3%
1.34USD 3,965 |
2,957 -8.3% | 1.34 | USD 3,965 | |
| 2025-01-07 | 2025-01-03 | PS Planned sale |
Chief Development Officer Officer |
2,957
-9.0%
1.34USD 3,965 |
2,957 -9.0% | 1.34 | USD 3,965 | |
| 2025-01-07 | 2025-01-03 | S Sale |
Chief Strategy Officer Officer |
2,029
-5.7%
1.34USD 2,721 |
2,029 -5.7% | 1.34 | USD 2,721 | |
| 2025-01-07 | 2025-01-03 | S Sale |
See Remarks Officer |
9,663
-7.6%
1.34USD 12,958 |
9,663 -7.6% | 1.34 | USD 12,958 | |
| 2024-12-10 | 2024-12-10 | B Purchase | Non-Executive Director |
5,000
+0.8%
1.49USD 7,468 |
5,000 +0.8% | 1.49 | USD 7,468 | |
| 2024-12-10 | 2024-12-10 | B Purchase | Non-Executive Director |
5,000
+0.9%
1.49USD 7,462 |
5,000 +0.9% | 1.49 | USD 7,462 | |
| 2024-12-10 | 2024-12-09 | B Purchase | Non-Executive Director |
18,483
+2.9%
1.43USD 26,407 |
18,483 +2.9% | 1.43 | USD 26,407 | |
| 2024-12-10 | 2024-12-09 | B Purchase | Non-Executive Director |
12,289
+2.2%
1.43USD 17,577 |
12,289 +2.2% | 1.43 | USD 17,577 | |
| 2024-12-10 | 2024-12-06 | B Purchase | Non-Executive Director |
6,517
+1.0%
1.45USD 9,427 |
6,517 +1.0% | 1.45 | USD 9,427 | |
| 2024-12-10 | 2024-12-06 | B Purchase | Non-Executive Director |
12,711
+2.3%
1.45USD 18,367 |
12,711 +2.3% | 1.45 | USD 18,367 | |
| 2024-11-27 | 2024-11-27 | B Purchase | Non-Executive Director |
25,000
+4.2%
1.42USD 35,418 |
25,000 +4.2% | 1.42 | USD 35,418 | |
| 2024-11-27 | 2024-11-27 | B Purchase | Non-Executive Director |
25,000
+4.7%
1.42USD 35,423 |
25,000 +4.7% | 1.42 | USD 35,423 | |
| 2024-11-27 | 2024-11-27 | B Purchase | Non-Executive Director |
2,000
+1.6%
1.40USD 2,800 |
2,000 +1.6% | 1.40 | USD 2,800 | |
| 2024-11-27 | 2024-11-26 | B Purchase | Non-Executive Director |
12,500
+2.1%
1.39USD 17,428 |
12,500 +2.1% | 1.39 | USD 17,428 | |
| 2024-11-27 | 2024-11-26 | B Purchase | Non-Executive Director |
12,500
+2.4%
1.39USD 17,418 |
12,500 +2.4% | 1.39 | USD 17,418 | |
| 2024-11-21 | 2024-11-20 | B Purchase | Non-Executive Director |
25,000
+5.1%
1.15USD 28,870 |
25,000 +5.1% | 1.15 | USD 28,870 | |
| 2024-11-21 | 2024-11-20 | B Purchase | Non-Executive Director |
25,000
+4.5%
1.16USD 29,000 |
25,000 +4.5% | 1.16 | USD 29,000 | |
| 2024-11-21 | 2024-11-19 | B Purchase | Non-Executive Director |
75,000
+18.1%
1.04USD 77,730 |
75,000 +18.1% | 1.04 | USD 77,730 | |
| 2024-11-21 | 2024-11-19 | B Purchase | Non-Executive Director |
75,000
+15.5%
1.03USD 77,528 |
75,000 +15.5% | 1.03 | USD 77,528 | |
| 2024-11-20 | 2024-11-19 | B Purchase | Non-Executive Director |
5,000
+4.2%
1.01USD 5,050 |
5,000 +4.2% | 1.01 | USD 5,050 | |
| 2024-11-20 | 2024-11-18 | B Purchase | Non-Executive Director |
20,000
+20.4%
1.00USD 19,996 |
20,000 +20.4% | 1.00 | USD 19,996 | |
| 2024-11-18 | 2024-11-18 | B Purchase |
Chief Executive Officer Executive Director |
50,000
+4.9%
1.00USD 49,970 |
50,000 +4.9% | 1.00 | USD 49,970 | |
| 2024-08-14 | 2024-08-14 | B Purchase | Large shareholder |
1,500,000
+35.3%
1.04USD 1,560,000 |
1,500,000 +35.3% | 1.04 | USD 1,560,000 | |
| 2024-08-13 | 2024-08-09 | S Sale | Large shareholder |
114,759
-27.6%
1.08USD 123,940 |
114,759 -27.6% | 1.08 | USD 123,940 | |
| 2024-08-13 | 2024-08-09 | S Sale | Large shareholder |
3,410,335
-66.4%
1.08USD 3,683,162 |
3,410,335 -66.4% | 1.08 | USD 3,683,162 | |
| 2024-01-19 | 2024-01-18 | S Sale | Non-Executive Director |
100,000
-19.8%
19.11USD 1,911,410 |
100,000 -19.8% | 19.11 | USD 1,911,410 | |
| 2024-01-18 | 2024-01-16 | S Sale | Non-Executive Director |
15,907
-4.0%
19.65USD 312,573 |
15,907 -4.0% | 19.65 | USD 312,573 | |
| 2024-01-18 | 2024-01-16 | S Sale | Non-Executive Director |
84,093
-4.0%
19.65USD 1,652,427 |
84,093 -4.0% | 19.65 | USD 1,652,427 | |
| 2024-01-18 | 2024-01-16 | S Sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
15,907
-4.0%
19.65USD 312,573 |
15,907 -4.0% | 19.65 | USD 312,573 | |
| 2024-01-18 | 2024-01-16 | S Sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
84,093
-4.0%
19.65USD 1,652,427 |
84,093 -4.0% | 19.65 | USD 1,652,427 | |
| 2024-01-17 | 2024-01-12 | PS Planned sale | Non-Executive Director |
719
-0.1%
21.91USD 15,753 |
719 -0.1% | 21.91 | USD 15,753 | |
| 2024-01-17 | 2024-01-12 | PS Planned sale | Non-Executive Director |
706
-0.2%
21.92USD 15,476 |
706 -0.2% | 21.92 | USD 15,476 | |
| 2024-01-12 | 2024-01-10 | PS Planned sale | Non-Executive Director |
1,800
-0.4%
21.92USD 39,456 |
1,800 -0.4% | 21.92 | USD 39,456 | |
| 2024-01-12 | 2024-01-10 | PS Planned sale | Non-Executive Director |
1,869
-0.4%
21.93USD 40,987 |
1,869 -0.4% | 21.93 | USD 40,987 | |
| 2024-01-11 | 2024-01-09 | PS Planned sale |
Chief Strategy Officer Officer |
7,417
-79.5%
20.14USD 149,367 |
7,417 -79.5% | 20.14 | USD 149,367 | |
| 2024-01-04 | 2024-01-02 | PS Planned sale |
Chief Strategy Officer Officer |
2,583
-57.4%
20.12USD 51,967 |
2,583 -57.4% | 20.12 | USD 51,967 | |
| 2024-01-04 | 2024-01-02 | PS Planned sale |
Chief Executive Officer Executive Director |
2,777
-56.6%
20.09USD 55,802 |
2,777 -56.6% | 20.09 | USD 55,802 | |
| 2023-11-16 | 2023-11-14 | PS Planned sale | Non-Executive Director Large shareholder |
288
-0.1%
16.15USD 4,650 |
288 -0.1% | 16.15 | USD 4,650 | |
| 2023-11-16 | 2023-11-14 | PS Planned sale | Non-Executive Director Large shareholder |
1,522
-0.1%
16.15USD 24,574 |
1,522 -0.1% | 16.15 | USD 24,574 | |
| 2023-11-16 | 2023-11-14 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
288
-0.1%
16.15USD 4,650 |
288 -0.1% | 16.15 | USD 4,650 | |
| 2023-11-16 | 2023-11-14 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
1,522
-0.1%
16.15USD 24,574 |
1,522 -0.1% | 16.15 | USD 24,574 | |
| 2023-10-03 | 2023-10-02 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
902
-0.2%
16.07USD 14,495 |
902 -0.2% | 16.07 | USD 14,495 | |
| 2023-10-03 | 2023-10-02 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
4,770
-0.2%
16.07USD 76,654 |
4,770 -0.2% | 16.07 | USD 76,654 | |
| 2023-10-03 | 2023-10-02 | PS Planned sale | Non-Executive Director Large shareholder |
902
-0.2%
16.07USD 14,495 |
902 -0.2% | 16.07 | USD 14,495 | |
| 2023-10-03 | 2023-10-02 | PS Planned sale | Non-Executive Director Large shareholder |
4,770
-0.2%
16.07USD 76,654 |
4,770 -0.2% | 16.07 | USD 76,654 | |
| 2023-10-03 | 2023-09-29 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
15,764
-3.8%
16.28USD 256,638 |
15,764 -3.8% | 16.28 | USD 256,638 | |
| 2023-10-03 | 2023-09-29 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
83,337
-3.8%
16.28USD 1,356,726 |
83,337 -3.8% | 16.28 | USD 1,356,726 | |
| 2023-10-03 | 2023-09-29 | PS Planned sale | Non-Executive Director Large shareholder |
15,764
-3.8%
16.28USD 256,638 |
15,764 -3.8% | 16.28 | USD 256,638 | |
| 2023-10-03 | 2023-09-29 | PS Planned sale | Non-Executive Director Large shareholder |
83,337
-3.8%
16.28USD 1,356,726 |
83,337 -3.8% | 16.28 | USD 1,356,726 | |
| 2023-09-29 | 2023-09-28 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
1,356
-0.3%
16.11USD 21,845 |
1,356 -0.3% | 16.11 | USD 21,845 | |
| 2023-09-29 | 2023-09-28 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
7,160
-0.3%
16.11USD 115,348 |
7,160 -0.3% | 16.11 | USD 115,348 | |
| 2023-09-29 | 2023-09-28 | PS Planned sale | Non-Executive Director Large shareholder |
1,356
-0.3%
16.11USD 21,845 |
1,356 -0.3% | 16.11 | USD 21,845 | |
| 2023-09-29 | 2023-09-28 | PS Planned sale | Non-Executive Director Large shareholder |
7,160
-0.3%
16.11USD 115,348 |
7,160 -0.3% | 16.11 | USD 115,348 | |
| 2023-09-29 | 2023-09-27 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
134
-0.0%
16.07USD 2,153 |
134 -0.0% | 16.07 | USD 2,153 | |
| 2023-09-29 | 2023-09-27 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
707
-0.0%
16.07USD 11,361 |
707 -0.0% | 16.07 | USD 11,361 | |
| 2023-09-29 | 2023-09-27 | PS Planned sale | Non-Executive Director Large shareholder |
134
-0.0%
16.07USD 2,153 |
134 -0.0% | 16.07 | USD 2,153 | |
| 2023-09-29 | 2023-09-27 | PS Planned sale | Non-Executive Director Large shareholder |
707
-0.0%
16.07USD 11,361 |
707 -0.0% | 16.07 | USD 11,361 | |
| 2023-09-15 | 2023-09-13 | PS Planned sale | Non-Executive Director Large shareholder |
64
-0.0%
16.00USD 1,024 |
64 -0.0% | 16.00 | USD 1,024 | |
| 2023-09-15 | 2023-09-13 | PS Planned sale | Non-Executive Director Large shareholder |
336
-0.0%
16.00USD 5,376 |
336 -0.0% | 16.00 | USD 5,376 | |
| 2023-09-15 | 2023-09-13 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
64
-0.0%
16.00USD 1,024 |
64 -0.0% | 16.00 | USD 1,024 | |
| 2023-09-15 | 2023-09-13 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
336
-0.0%
16.00USD 5,376 |
336 -0.0% | 16.00 | USD 5,376 | |
| 2023-09-08 | 2023-09-07 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
537
-0.1%
16.05USD 8,619 |
537 -0.1% | 16.05 | USD 8,619 | |
| 2023-09-08 | 2023-09-07 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
2,841
-0.1%
16.05USD 45,598 |
2,841 -0.1% | 16.05 | USD 45,598 | |
| 2023-09-08 | 2023-09-07 | PS Planned sale | Non-Executive Director Large shareholder |
537
-0.1%
16.05USD 8,619 |
537 -0.1% | 16.05 | USD 8,619 | |
| 2023-09-08 | 2023-09-07 | PS Planned sale | Non-Executive Director Large shareholder |
2,841
-0.1%
16.05USD 45,598 |
2,841 -0.1% | 16.05 | USD 45,598 | |
| 2023-09-08 | 2023-09-06 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
598
-0.1%
16.02USD 9,580 |
598 -0.1% | 16.02 | USD 9,580 | |
| 2023-09-08 | 2023-09-06 | PS Planned sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
3,164
-0.1%
16.02USD 50,687 |
3,164 -0.1% | 16.02 | USD 50,687 | |
| 2023-09-08 | 2023-09-06 | PS Planned sale | Non-Executive Director Large shareholder |
598
-0.1%
16.02USD 9,580 |
598 -0.1% | 16.02 | USD 9,580 | |
| 2023-09-08 | 2023-09-06 | PS Planned sale | Non-Executive Director Large shareholder |
3,164
-0.1%
16.02USD 50,687 |
3,164 -0.1% | 16.02 | USD 50,687 | |
| 2023-08-25 | 2023-08-23 | S Sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
64
-0.0%
16.00USD 1,024 |
64 -0.0% | 16.00 | USD 1,024 | |
| 2023-08-25 | 2023-08-23 | S Sale |
Adjuvant Global Health Technology Fund, L.P. Large shareholder |
336
-0.0%
16.00USD 5,376 |
336 -0.0% | 16.00 | USD 5,376 | |
| 2023-08-25 | 2023-08-23 | S Sale | Non-Executive Director Large shareholder |
64
-0.0%
16.00USD 1,024 |
64 -0.0% | 16.00 | USD 1,024 | |
| 2023-08-25 | 2023-08-23 | S Sale | Non-Executive Director Large shareholder |
336
-0.0%
16.00USD 5,376 |
336 -0.0% | 16.00 | USD 5,376 | |
| 2023-08-22 | 2023-08-18 | B Purchase | Large shareholder |
1,777,778
+52.9%
9.00USD 16,000,002 |
1,777,778 +52.9% | 9.00 | USD 16,000,002 | |
| 2023-05-15 | 2023-05-15 | B Purchase |
Chief Executive Officer Executive Director |
10,000
+1.0%
5.38USD 53,770 |
10,000 +1.0% | 5.38 | USD 53,770 |